Improving pathology services with a new automatic autostainer
A multiplex automatic autostainer at Jefferson
This study is all about getting a new machine for the cancer lab that will help doctors process patient samples faster and more accurately, which means better tests and treatments for people with cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Thomas Jefferson University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10852635 on NIH RePORTER |
What this research studies
This research focuses on enhancing the capabilities of the Translational Pathology Shared Resource (TPSR) laboratory at the Sidney Kimmel Cancer Center by acquiring a new automatic autostainer. The new equipment will allow for faster and more efficient processing of patient samples, enabling advanced molecular pathology techniques such as multiplexed immunohistochemistry and in situ hybridization. This upgrade aims to improve the quality of diagnostic services provided to patients and support ongoing clinical trials and research efforts. By streamlining the pathology workflow, the project seeks to enhance the overall efficiency of cancer research and treatment.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include cancer patients whose samples are analyzed for diagnostic and treatment purposes.
Not a fit: Patients who are not undergoing diagnostic testing or treatment at the Sidney Kimmel Cancer Center may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more accurate diagnoses for cancer patients, ultimately improving treatment outcomes.
How similar studies have performed: Other research has shown success with similar advancements in pathology technology, indicating a strong potential for improved patient outcomes.
Where this research is happening
Philadelphia, United States
- Thomas Jefferson University — Philadelphia, United States (Active)
Researchers
- Principal investigator: Yang, Haifeng — Thomas Jefferson University
- Study coordinator: Yang, Haifeng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.